Both Bio-AX projects (2015 Phase 1 and 2016 Phase 2) centre on a body-worn biometric device capable of accurate, high-throughput identification.
AUDAX GLOBAL SOLUTIONS LIMITED
UK SME developing wearable body-worn biometric identification devices for security and law enforcement field use.
Their core work
Audax Global Solutions is a UK-based technology SME specialising in wearable biometric identification systems, primarily for security and law enforcement applications. Their core product, Bio-AX, is a body-worn video device that combines non-invasive biometric capture with real-time identification — enabling officers in the field to verify identities without physical contact or specialised equipment. They progressed through the EU SME Instrument from feasibility (Phase 1) to market development (Phase 2), which indicates a product that cleared proof-of-concept and entered commercialisation. Their work sits at the intersection of biometric sensing, wearable hardware, and security operations technology.
What they specialise in
The BIO-AX Phase 2 description explicitly describes a 'biometric body worn video solution', indicating hardware integration of camera and biometric capture.
Both project descriptions emphasise 'non-invasive' biometric methods, pointing to expertise in contactless sensing modalities such as facial, iris, or gait recognition.
Both projects are funded under the H2020 Security pillar (P3-SECURITY), indicating the intended application domain is public safety or border/access control.
How they've shifted over time
Audax Global's H2020 history is a single, focused technology trajectory rather than a portfolio of diverse themes: they developed one biometric wearable product and scaled it from feasibility study to commercial launch within two years. There is no evidence of a pivot or diversification — Phase 1 (2015) and Phase 2 (2016) are the same Bio-AX concept at successive maturity levels. This consistency suggests a company built around one product rather than a broad research agenda, which limits what can be inferred about evolving priorities beyond "they took their product to market."
Their trajectory through the SME Instrument suggests a company focused on bringing a specific security hardware product to market — any future collaboration would likely involve field trials, integration partnerships, or expansion into adjacent biometric use cases such as border control or access management.
How they like to work
Audax Global coordinated both of their H2020 projects as the sole beneficiary, which is typical of SME Instrument grants that are designed for individual companies rather than consortia. They show no recorded consortium partners across either project, meaning there is no visible track record of multi-partner collaboration within the EU funding system. Working with them would likely mean engaging directly with the company as a bilateral technology or integration partner rather than through a shared consortium structure.
Audax Global has no recorded consortium partners from their H2020 participation — both grants were single-entity SME Instrument awards. Their collaboration network within EU-funded research is effectively absent from the available data.
What sets them apart
Audax Global is one of the few UK SMEs to have successfully progressed through both phases of the H2020 SME Instrument in the security domain, which is a meaningful signal of product viability — the European Commission's evaluators validated the concept twice. Their differentiation is specificity: they are not a general biometrics company but a team that built a single deployable product (body-worn biometric video) for operational security use. For a consortium needing a security hardware demonstrator or a field-deployable biometric component, they offer a market-validated device rather than a research prototype.
Highlights from their portfolio
- BIO-AXThe Phase 2 grant of €772,283 represents a full commercial scale-up award, confirming that the European Commission judged the biometric wearable concept both technically sound and market-ready.
- Bio-AXThe Phase 1 feasibility grant (€50,000) launched the product concept under the Security pillar, establishing Audax Global's entry into EU-funded security technology development.